Bay Rivers Group’s AbbVie ABBV Stock Holding History

Bay Rivers Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305K	Buy	+1,211	New	+$261K	0.1%	103
2022 Q2	–	Sell	-8,941	Closed	-$1.45M	–	62
2022 Q1	$1.45M	Sell	8,941 -3,678	-29%	-$534K	1.04%	35
2021 Q4	$1.71M	Buy	12,619 +514	+4%	+$60.7K	1.04%	38
2021 Q3	$1.31M	Buy	+12,105	New	+$1.38M	0.89%	41

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Bay Rivers Group's ABBV Position: Q2 2026 in Review

Bay Rivers Group opened a new position in AbbVie (ABBV) in Q2 2026: 1,211 shares worth $305K. The stake represents 0.1% of the portfolio and ranks #103 among its holdings. This is a return to the name: Bay Rivers Group previously reported a position in ABBV as recently as Q1 2022.

Bay Rivers Group first reported a position in ABBV in Q3 2021 and has held it in 4 quarters since. The position peaked at $1.71M in Q4 2021. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bay Rivers Group held 1,211 shares of AbbVie worth $305K as of Q2 2026.
AbbVie was a new Bay Rivers Group position in Q2 2026.
AbbVie made up 0.1% of Bay Rivers Group's portfolio in Q2 2026, its #103 holding.
Bay Rivers Group first reported a position in AbbVie in Q3 2021 and has held it in 4 quarters since.
Bay Rivers Group's AbbVie position peaked at $1.71M in Q4 2021.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bay Rivers Group's 13F filing for Q2 2026, filed 9 Jul 2026.